Insight

Johnson & Johnson Innovation aims for disruption

Johnson & Johnson Innovation aims for disruption

Johnson & Johnson Innovation, Boston, has high expectations for itself and its partners. "We're looking for ideas that will make a tremendous difference in patients' lives, not merely incremental progress," said Robert G. Urban, PhD, head of Johnson & Johnson Innovation, Boston. To do that, "we take advantage of the deep science emerging around us to develop bold platforms that make a big difference.

RA Capital: Flexibility builds innovation


Aug 29, 2015

Flexibility is the watchword for investment at RA Capital Management. As Peter Kolchinsky, managing director, explained, "Investors should be as flexible as possible. Therefore, we're...

Patient-centric Baxalta capitalizes on Cambridge

Patient-centric Baxalta capitalizes on Cambridge


Jul 21, 2015

When Baxalta Incorporated spun out of Baxter on July 1, it already qualified as "big pharma." With USD 6 billion in annual revenues, 16,000 employees,...

partnering360®: leverage and cultivate your dealmaker network

partnering360 is the network for dealmakers in the life science industry. This global community of more than 30,000 is constantly growing, and the partnering opportunities continually updating.